Skip to Main Content

Paper Details

Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours.
Anticancer Res
2
2022
AML, Acute Leukemia, Brain Tumours, GBM, MB, NB, Neuroendocrine Tumours, PI3K, PI3KC2, SCLC, acute myeloid leukemia, brain tumours, cancer, cancer cells, cell lines, class II PI3KC2, class II PI3Ks, glioblastoma multiforme, human, human cancer cell lines, human catalytic phosphoinositide 3-kinase, malignancies, medulloblastoma, neuroblastoma, neuroendocrine tumours, primary cultures, small cell lung cancer, tumour, tumours
Author NameAffiliation
Marin MarinovDivision of Clinical Chemistry and Biochemistry, and University Children's Hospital Zurich
Olivier DelattreINSERM U
Michael A GrotzerUniversity Children's Hospital Zurich
Karl FreiUniversity Hospital Zurich
  • 1 - 4

Datasets

Release 1.2